Search

Your search keyword '"Raphael, Martine F."' showing total 27 results
Start Over Author "Raphael, Martine F." Search Limiters Full Text
27 results on '"Raphael, Martine F."'

1. Experiences with a national team-based learning program for advance care planning in pediatric palliative care

Author

Palliatieve Zorg, Intensive care patientenzorg, Expertisecentrum Alg., Cancer, Child Health, Engel, Marijanne, Fahner, Jurrianne C., Hennus, Marije P., Brounen, Marie-José, van Capelle, Carine, de Groot, Marinka A.R., Hermans-Peters, Marion, Hofman, Suzanne C., Joosen, Cindy, Lalbahadoersing-Jharap, Sarmila, Maebe, Sofie, Michiels, Erna M.C., Miedema, Suzanna, Raphael, Martine F, Schieving, Jolanda H., de Weerd, Willemien, Kars, MC, Palliatieve Zorg, Intensive care patientenzorg, Expertisecentrum Alg., Cancer, Child Health, Engel, Marijanne, Fahner, Jurrianne C., Hennus, Marije P., Brounen, Marie-José, van Capelle, Carine, de Groot, Marinka A.R., Hermans-Peters, Marion, Hofman, Suzanne C., Joosen, Cindy, Lalbahadoersing-Jharap, Sarmila, Maebe, Sofie, Michiels, Erna M.C., Miedema, Suzanna, Raphael, Martine F, Schieving, Jolanda H., de Weerd, Willemien, and Kars, MC

Published
2024

2. Mental Health of School-Aged Children Treated with Propranolol or Atenolol for Infantile Hemangioma and Their Parents

Author

Hermans, Mireille M., Schappin, Renske, De Laat, Peter C.J., Mendels, Elodie J., Breur, Johannes M.P.J., Langeveld, Hester R., Raphael, Martine F., De Graaf, Marlies, Breugem, Corstiaan C., De Wildt, Saskia N., Okkerse, Jolanda M.E., Pasmans, Suzanne G.M.A., Rietman, André B., Hermans, Mireille M., Schappin, Renske, De Laat, Peter C.J., Mendels, Elodie J., Breur, Johannes M.P.J., Langeveld, Hester R., Raphael, Martine F., De Graaf, Marlies, Breugem, Corstiaan C., De Wildt, Saskia N., Okkerse, Jolanda M.E., Pasmans, Suzanne G.M.A., and Rietman, André B.

Abstract

Background: Infants with infantile hemangioma (IH) have been effectively treated with propranolol or atenolol. Concerns were raised about the mental health of these The trial registration: Netherlands Trial Register Trial NL7703.children at school age, due to central nervous system effects of propranolol and visible nature of IH. Objective: This study aimed to compare the mental health at school age of children treated with propranolol to children treated with atenolol for IHs and their parents. Methods: This two-centered cross sectional study included children aged =6 years and treated with either propranolol or atenolol for IH during infancy. Children’s outcomes were performance-based affect recognition (Dutch version of the Developmental Neuropsychological Assessment-II [NEPSY-II-NL]), parent-reported emotional and behavioral functioning (Child Behavioral Checklist [CBCL]), and health-related quality of life (KIDSCREEN27). Parents’ outcome was parenting stress (Parenting Stress Questionnaire [OBVL]). Results: Data of 105 children (36 propranolol, 69 atenolol; 6.0–11.8 years) were analyzed. Mental health outcomes did not differ between both ß-blocker groups. Although overall functioning was in line with norms, children presented specific problems concerning affect recognition, parent-reported attention, and social quality of life. Parents showed increased physical symptoms, depressive symptoms, and parent-child relationship problems. Conclusion: No difference in mental health at school age was found between children treated with propranolol or atenolol for IH. Although few overall mental health problems were found, specific problems require follow-up. Follow-up of children should be directed toward affect recognition, attention, and social functioning in daily life. Problems reported by parents could be ameliorated by mental health support during and after their in

Published
2024

3. Mental health of school-aged children treated with propranolol or atenolol for infantile hemangioma and their parents

Author

E&R onderzoek, Cardiologie onderzoek 1, Child Health, Circulatory Health, Regenerative Medicine and Stem Cells, MS Dermatologie/Allergologie, Infection & Immunity, Zorgeenheid Plastische Chirurgie Medisch, Hermans, Mireille M, Schappin, Renske, de Laat, Peter C J, Mendels, Elodie J, Breur, Johannes M P J, Langeveld, Hester R, Raphael, Martine F, de Graaf, Marlies, Breugem, Corstiaan C, de Wildt, Saskia N, Okkerse, Jolanda M E, Pasmans, Suzanne G M A, Rietman, André B, E&R onderzoek, Cardiologie onderzoek 1, Child Health, Circulatory Health, Regenerative Medicine and Stem Cells, MS Dermatologie/Allergologie, Infection & Immunity, Zorgeenheid Plastische Chirurgie Medisch, Hermans, Mireille M, Schappin, Renske, de Laat, Peter C J, Mendels, Elodie J, Breur, Johannes M P J, Langeveld, Hester R, Raphael, Martine F, de Graaf, Marlies, Breugem, Corstiaan C, de Wildt, Saskia N, Okkerse, Jolanda M E, Pasmans, Suzanne G M A, and Rietman, André B

Published
2024

5. Prognostic Factors for Long-term Aesthetic Outcome of Infantile Haemangioma Treated with Beta-blockers

Author

Hermans, Mireille M., primary, Pasmans, Suzanne G.M.A., additional, De Graaf, Marlies, additional, Ragamin, Aviël, additional, Mendels, Elodie J., additional, Breur, Johannes M.P.J., additional, Langeveld, Hester R., additional, Raphael, Martine F., additional, De Laat, Peter C.J., additional, De Wildt, Saskia N., additional, Rietman, André B., additional, Breugem, Corstiaan C., additional, and Schappin, Renske, additional

Published
2023
Full Text
View/download PDF

6. Prognostic Factors for Long-term Aesthetic Outcome of Infantile Haemangioma Treated with Beta-blockers

Author

Hermans, Mireille M., Pasmans, Suzanne G.M.A., De Graaf, Marlies, Ragamin, Aviël, Mendels, Elodie J., Breur, Johannes M.P.J., Langeveld, Hester R., Raphael, Martine F., De Laat, Peter C.J., De Wildt, Saskia N., Rietman, André B., Breugem, Corstiaan C., Schappin, Renske, Hermans, Mireille M., Pasmans, Suzanne G.M.A., De Graaf, Marlies, Ragamin, Aviël, Mendels, Elodie J., Breur, Johannes M.P.J., Langeveld, Hester R., Raphael, Martine F., De Laat, Peter C.J., De Wildt, Saskia N., Rietman, André B., Breugem, Corstiaan C., and Schappin, Renske

Abstract

Parents of infants treated with beta-blockers for infantile haemangioma are often concerned about the long-term aesthetic outcome. This cross-sectional study assessed the influence on the long-term aesthetic outcome of characteristics of the infantile haemangioma, the beta-blocker treatment, and the infant. The study included 103 children aged 6-12 years, treated with beta-blockers (propranolol or atenolol) for infantile haemangioma during infancy (age at treatment initiation ≤1 year) for ≥6 months. Dermatologists and parents scored the Patient Observer Scar Assessment Scale, and the child scored a visual analogue scale. Dermatologists identified whether telangiectasia, fibrofatty tissue, and atrophic scar tissue were present. The long-term aesthetic outcome of infantile haemangioma was judged more negatively by dermatologists and parents in case of a superficial component, ulceration, older age at treatment initiation, higher cumulative dose, and/or shorter follow-up time. According to children, infantile haemangioma located on the head had better aesthetic outcome than infantile haemangioma located elsewhere. Close monitoring, particularly of infantile haemangioma with a superficial component, is essential for early initiation of treatment, and to prevent or treat ulceration. These outcome data can support parental counselling and guide treatment strategy.

Published
2023

7. Propranolol or atenolol for the management of infantile hemangioma:Implications for long-term health

Author

Hermans, Mireille M., Pasmans, Suzanne G.M.A., de Laat, Peter C.J., Slieker, Martijn G., Mendels, Elodie J., de Graaf, Marlies, Langeveld, Hester R., Schappin, Renske, Rietman, André B., Breugem, Corstiaan C., Breur, Johannes M.P.J., de Wildt, Saskia N., Raphael, Martine F., Hermans, Mireille M., Pasmans, Suzanne G.M.A., de Laat, Peter C.J., Slieker, Martijn G., Mendels, Elodie J., de Graaf, Marlies, Langeveld, Hester R., Schappin, Renske, Rietman, André B., Breugem, Corstiaan C., Breur, Johannes M.P.J., de Wildt, Saskia N., and Raphael, Martine F.

Published
2023

8. Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma

Author

Hermans, Mireille M., Rietman, André B., Schappin, Renske, de Laat, Peter C.J., Mendels, Elodie J., Breur, Johannes M.P.J., Langeveld, Hester R., de Wildt, Saskia N., Breugem, Corstiaan C., de Graaf, Marlies, Raphael, Martine F., Pasmans, Suzanne G.M.A., Hermans, Mireille M., Rietman, André B., Schappin, Renske, de Laat, Peter C.J., Mendels, Elodie J., Breur, Johannes M.P.J., Langeveld, Hester R., de Wildt, Saskia N., Breugem, Corstiaan C., de Graaf, Marlies, Raphael, Martine F., and Pasmans, Suzanne G.M.A.

Abstract

The purpose of this study was to compare long-term neurocognitive functioning (working memory, processing speed, and attention) between children who had been treated with either propranolol or atenolol for infantile hemangioma during infancy. All eligible children (n = 158) aged 6 years or older and treated with propranolol or atenolol as infants were invited to participate in this two-center cross-sectional study. The primary outcome was the Wechsler Intelligence Scale for Children-V Cognitive Proficiency Index (CPI), a measure of working memory, processing speed, and attention. Secondary outcomes were general intelligence, auditory, visuospatial, and narrative memory, as well as executive functioning and sleep. A total of 105 children, of whom 36 had been treated with propranolol (age 6.0–11.8 years, follow-up time 1.6–9.7 years, 19% male) and 69 had been treated with atenolol (age 6.9–9.7 years, follow-up time 4.5–8.4 years, 19% male), were analyzed. The CPI and other neurocognitive outcomes did not differ between the propranolol and atenolol groups and were in line with general population test norms. Post hoc analyses revealed lower CPI scores for males, both compared to participating females (10.3 IQ points, medium effect size) and compared to matched test norms (12.4 IQ points, medium effect size). Conclusions: Long-term neurocognitive functioning did not differ between children treated with propranolol and those treated with atenolol for IH. Overall, propranolol and atenolol appear to be safe treatments for IH regarding long-term neurocognitive functioning. The substantially lower CPI scores in males warrant further investigation. Trial registration: Netherlands Trial Register, NL7703 https://www.trialregister.nl/trial/7703 What is Known:• Infants with infantile hemangioma are effectively treated with propranolol or atenolol.• Parents and professionals are concerned about long-term neurocognitive effects.What is New:• No long-term (≥ 6 years) differences i

Published
2023

9. Prognostic Factors for Long-term Aesthetic Outcome of Infantile Haemangioma Treated with Beta-blockers

Author

MS Dermatologie/Allergologie, Infection & Immunity, Cardiologie onderzoek 1, Child Health, Circulatory Health, Regenerative Medicine and Stem Cells, E&R onderzoek, Zorgeenheid Plastische Chirurgie Zorg, Hermans, Mireille M., Pasmans, Suzanne G.M.A., De Graaf, Marlies, Ragamin, Aviël, Mendels, Elodie J., Breur, Johannes M.P.J., Langeveld, Hester R., Raphael, Martine F., De Laat, Peter C.J., De Wildt, Saskia N., Rietman, André B., Breugem, Corstiaan C., Schappin, Renske, MS Dermatologie/Allergologie, Infection & Immunity, Cardiologie onderzoek 1, Child Health, Circulatory Health, Regenerative Medicine and Stem Cells, E&R onderzoek, Zorgeenheid Plastische Chirurgie Zorg, Hermans, Mireille M., Pasmans, Suzanne G.M.A., De Graaf, Marlies, Ragamin, Aviël, Mendels, Elodie J., Breur, Johannes M.P.J., Langeveld, Hester R., Raphael, Martine F., De Laat, Peter C.J., De Wildt, Saskia N., Rietman, André B., Breugem, Corstiaan C., and Schappin, Renske

Published
2023

10. Correction to: Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma (European Journal of Pediatrics, (2022), 182, 2, (757-767), 10.1007/s00431-022-04674-7)

Author

E&R onderzoek, Cardiologie onderzoek 1, Child Health, Circulatory Health, Regenerative Medicine and Stem Cells, Zorgeenheid Plastische Chirurgie Medisch, MS Dermatologie/Allergologie, Infection & Immunity, Hermans, Mireille M, Rietman, André B, Schappin, Renske, de Laat, Peter C J, Mendels, Elodie J, Breur, Johannes M P J, Langeveld, Hester R, de Wildt, Saskia N, Breugem, Corstiaan C, de Graaf, Marlies, Raphael, Martine F, Pasmans, Suzanne G M A, E&R onderzoek, Cardiologie onderzoek 1, Child Health, Circulatory Health, Regenerative Medicine and Stem Cells, Zorgeenheid Plastische Chirurgie Medisch, MS Dermatologie/Allergologie, Infection & Immunity, Hermans, Mireille M, Rietman, André B, Schappin, Renske, de Laat, Peter C J, Mendels, Elodie J, Breur, Johannes M P J, Langeveld, Hester R, de Wildt, Saskia N, Breugem, Corstiaan C, de Graaf, Marlies, Raphael, Martine F, and Pasmans, Suzanne G M A

Published
2023

11. Propranolol or atenolol for the management of infantile hemangioma: Implications for long-term health

Author

E&R onderzoek, Cardiologie patientenzorg, Child Health, Circulatory Health, MS Dermatologie/Allergologie, Infection & Immunity, Zorgeenheid Plastische Chirurgie Medisch, Cardiologie onderzoek 1, Regenerative Medicine and Stem Cells, Hermans, Mireille M, Pasmans, Suzanne G M A, de Laat, Peter C J, Slieker, Martijn G, Mendels, Elodie J, de Graaf, Marlies, Langeveld, Hester R, Schappin, Renske, Rietman, André B, Breugem, Corstiaan C, Breur, Johannes M P J, de Wildt, Saskia N, Raphael, Martine F, E&R onderzoek, Cardiologie patientenzorg, Child Health, Circulatory Health, MS Dermatologie/Allergologie, Infection & Immunity, Zorgeenheid Plastische Chirurgie Medisch, Cardiologie onderzoek 1, Regenerative Medicine and Stem Cells, Hermans, Mireille M, Pasmans, Suzanne G M A, de Laat, Peter C J, Slieker, Martijn G, Mendels, Elodie J, de Graaf, Marlies, Langeveld, Hester R, Schappin, Renske, Rietman, André B, Breugem, Corstiaan C, Breur, Johannes M P J, de Wildt, Saskia N, and Raphael, Martine F

Published
2023

12. Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma

Author

E&R onderzoek, CTC, Child Health, Urologie Medisch Kinderen, Cardiologie onderzoek 1, Circulatory Health, Regenerative Medicine and Stem Cells, Zorgeenheid Plastische Chirurgie Medisch, MS Dermatologie/Allergologie, Infection & Immunity, Hermans, Mireille M., Rietman, André B., Schappin, Renske, de Laat, Peter C.J., Mendels, Elodie J., Breur, Johannes M.P.J., Langeveld, Hester R., de Wildt, Saskia N., Breugem, Corstiaan C., de Graaf, Marlies, Raphael, Martine F., Pasmans, Suzanne G.M.A., E&R onderzoek, CTC, Child Health, Urologie Medisch Kinderen, Cardiologie onderzoek 1, Circulatory Health, Regenerative Medicine and Stem Cells, Zorgeenheid Plastische Chirurgie Medisch, MS Dermatologie/Allergologie, Infection & Immunity, Hermans, Mireille M., Rietman, André B., Schappin, Renske, de Laat, Peter C.J., Mendels, Elodie J., Breur, Johannes M.P.J., Langeveld, Hester R., de Wildt, Saskia N., Breugem, Corstiaan C., de Graaf, Marlies, Raphael, Martine F., and Pasmans, Suzanne G.M.A.

Published
2023

13. Propranolol or atenolol for the management of infantile hemangioma: Implications for long-term health

Author

Hermans, Mireille M., primary, Pasmans, Suzanne G.M.A., additional, de Laat, Peter C.J., additional, Slieker, Martijn G., additional, Mendels, Elodie J., additional, de Graaf, Marlies, additional, Langeveld, Hester R., additional, Schappin, Renske, additional, Rietman, André B., additional, Breugem, Corstiaan C., additional, Breur, Johannes M.P.J., additional, de Wildt, Saskia N., additional, and Raphael, Martine F., additional

Published
2023
Full Text
View/download PDF

14. Correction to:Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma (European Journal of Pediatrics, (2022), 182, 2, (757-767), 10.1007/s00431-022-04674-7)

Author

Hermans, Mireille M., Rietman, André B., Schappin, Renske, de Laat, Peter C. J., Mendels, Elodie J., Breur, Johannes M. P. J., Langeveld, Hester R., de Wildt, Saskia N., Breugem, Corstiaan C., de Graaf, Marlies, Raphael, Martine F., and Pasmans, Suzanne G. M. A.

Abstract

In the original published version of the above article, the data reported with ‘yes’ and ‘no’ under "Child migration background" are switched up. The Table 1 below is the correct listing. (Table presented.) Participant characteristics All (n = 105) Propranolol (n = 36) Atenolol (n = 69) p-value Child age, years Median (IQR) 7.4 (6.7–8.5) 8.0 (7.3–8.8) 7.1 (6.4–8.1) 0.99 Male 20 (19) 7 (19) 13 (19) Child migration background a, n (%) Yes 10 (10) 0 (0.0) 10 (14) 0.01 No 94 (90) 36 (100) 58 (84) Unknown 1 (1.0) 0 (0.0) 1 (1.4) Education mother, n (%) Low 14 (13) 6 (17) 8 (12) 0.89 Average 28 (27) 8 (22) 20 (29) High 62 (59) 22 (61) 40 (58) Unknown 1 (1.0) 0 (0.0) 1 (1.4) Home language, n (%) Dutch 97 (92) 35 (97) 62 (90) 0.37 Other 2 (2.0) 0 (0.0) 2 (2.9) Multilingual 6 (5.7) 1 (2.8) 5 (7.2) Confirmed diagnosis, n (%) Attention deficit/hyperactivity disorder 6 (5.7) 3 (8.3) 3 (4.3) Location of IH b, n (%) Head and neck 84 (80) 24 (67) 60 (87) 0.02 Trunk 13 (12) 6 (17) 7 (10) 0.36 Genital area 13 (12) 7 (19) 6 (8.7) 0.13 Extremities 7 (6.7) 3 (8.3) 4 (5.8) 0.69 Ulcerated IH, n (%) Yes 29 (28) 13 (36) 16 (23) 0.16 No 76 (72) 23 (64) 53 (77) Treatment center, n (%) Erasmus MC 34 (32) 31 (86) 3 (4.3) c, years Median (IQR) 5.9 (5.2–6.5) 6.2 (5.6–6.6) 5.7 (5.1–6.2) 0.13 Range 1.6–9.7 1.6–9.7 4.5–8.4 p values indicate differences in participant characteristics between propranolol and atenolol group Continuous variables were not normally distributed and analyzed with a Mann-Whitney U test. Dichotomous variables were analyzed with a Fisher’s exact test aChild migration background, categorized as “yes” = one or both parents born abroad or “no” = both parents born in the Netherlands bA total of 105 patients had a total of 128 IH. The variable “location of IH” represents the number of children with at least one infantile hemangioma at each region cFollow-up time: time interval between cessation of beta-blocker treatment and neuropsychological assessment The original article has been corrected.

Published
2023
Full Text
View/download PDF

15. Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma

Author

Hermans, Mireille M., primary, Breugem, Corstiaan C., additional, Schappin, Renske, additional, Jonge Poerink, Emma, additional, Mendels, Elodie J., additional, Ragamin, Aviël, additional, Breur, Johannes M.P.J., additional, Langeveld, Hester R., additional, Raphael, Martine F., additional, De Laat, Peter C.J., additional, De Wildt, Saskia N., additional, Rietman, André B., additional, Pasmans, Suzanne G.M.A., additional, and De Graaf, Marlies, additional

Published
2022
Full Text
View/download PDF

16. Late Mortality in Childhood Cancer Survivors according to Pediatric Cancer Diagnosis and Treatment Era in the Dutch LATER Cohort

Author

Kilsdonk, Ellen, van Dulmen-den Broeder, Eline, van Leeuwen, Flora E., van den Heuvel-Eibrink, Marry M., Loonen, Jacqueline J., van der Pal, Helena J., Bresters, Dorine, Versluys, A. B., Pieters, Rob, Hauptmann, Michael, Jaspers, Monique W.M., Neggers, Sebastian J.C., Raphael, Martine F., Tissing, Wim J.E., Kremer, Leontine C.M., Ronckers, Cécile M., Kilsdonk, Ellen, van Dulmen-den Broeder, Eline, van Leeuwen, Flora E., van den Heuvel-Eibrink, Marry M., Loonen, Jacqueline J., van der Pal, Helena J., Bresters, Dorine, Versluys, A. B., Pieters, Rob, Hauptmann, Michael, Jaspers, Monique W.M., Neggers, Sebastian J.C., Raphael, Martine F., Tissing, Wim J.E., Kremer, Leontine C.M., and Ronckers, Cécile M.

Abstract

This multi-center cohort-study examined late mortality among 6,165 Dutch five-year childhood cancer survivors diagnosed 1963–2001. Clinical details and cause of death were based on medical records. Mortality was 12-fold that of the general population, with 51.3 additional deaths per 10,000 person-years (21.9 yrs median follow-up). Cumulative mortality 15 yrs post-diagnosis was 6.9%, predominantly from late recurrences; thereafter the absolute contribution of other health outcomes increased. Cumulative all-cause and recurrence-related mortality were highest for Central Nervous System and bone tumor survivors. All-cause, but not subsequent tumor and circulatory disease-related cumulative mortality, was highest for patients diagnosed 1963–1979 vs. later (p-trend <0.001).

Published
2022

17. Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma

Author

Hermans, Mireille M., Breugem, Corstiaan C., Schappin, Renske, Jonge Poerink, Emma, Mendels, Elodie J., Ragamin, Aviël, Breur, Johannes M.P.J., Langeveld, Hester R., Raphael, Martine F., De Laat, Peter C.J., De Wildt, Saskia N., Rietman, André B., Pasmans, Suzanne G.M.A., De Graaf, Marlies, Hermans, Mireille M., Breugem, Corstiaan C., Schappin, Renske, Jonge Poerink, Emma, Mendels, Elodie J., Ragamin, Aviël, Breur, Johannes M.P.J., Langeveld, Hester R., Raphael, Martine F., De Laat, Peter C.J., De Wildt, Saskia N., Rietman, André B., Pasmans, Suzanne G.M.A., and De Graaf, Marlies

Abstract

Infantile haemangiomas are common benign tumours of infancy, which can be treated effectively with beta-blockers such as propranolol and atenolol. Different types of beta-blockers may result in different long-term aesthetic outcomes. This study evaluated the difference in long-term aesthetic outcomes between infantile haemangiomas treated with either propranolol or atenolol, including the perspective of physicians, parents, and children. Children, aged ≥6 years, treated with propranolol or atenolol for infantile haemangioma during infancy, participated in this 2-centre cross-sectional study. The primary endpoint was change in appearance of the infantile haemangioma from pre-treatment to follow-up, using a physician-rated visual analogue scale (VAS). Secondary outcomes were the Patient Observer Scar Assessment Scale (physician- and parent-rated) and a VAS (child-rated), assessing the residual lesion. In total, 103 children (35 treated with propranolol, 68 with atenolol) were analysed. No differences were found between children treated with propranolol and children treated with atenolol on physician-rated VAS (p = 0.10) or any secondary outcomes. Physicians indicated a large aesthetic improve-ment from pre- treatment to follow-up. Physicians, parents and children were positive about the current state of the residual lesion. Minor sequelae were common (86%). These results, in combination with the favourable safety profile of atenolol, should be considered when choosing beta-blocker treatment for infantile haemangioma.

Published
2022

18. Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma

Author

MS Dermatologie/Allergologie, Infection & Immunity, Cardiologie onderzoek 1, Child Health, Circulatory Health, Regenerative Medicine and Stem Cells, Hermans, Mireille M, Breugem, Corstiaan C, Schappin, Renske, Jonge Poerink, Emma, Mendels, Elodie J, Ragamin, Aviël, Breur, Johannes M P J, Langeveld, Hester R, Raphael, Martine F, De Laat, Peter C J, De Wildt, Saskia N, Rietman, André B, Pasmans, Suzanne G M A, De Graaf, Marlies, MS Dermatologie/Allergologie, Infection & Immunity, Cardiologie onderzoek 1, Child Health, Circulatory Health, Regenerative Medicine and Stem Cells, Hermans, Mireille M, Breugem, Corstiaan C, Schappin, Renske, Jonge Poerink, Emma, Mendels, Elodie J, Ragamin, Aviël, Breur, Johannes M P J, Langeveld, Hester R, Raphael, Martine F, De Laat, Peter C J, De Wildt, Saskia N, Rietman, André B, Pasmans, Suzanne G M A, and De Graaf, Marlies

Published
2022

21. Iron refractory iron deficiency anemia : a heterogeneous disease that is not always iron refractory

Author

Donker, Albertine E, Schaap, Charlotte C M, Novotny, Vera M J, Smeets, Roel, Peters, Tessa M A, van den Heuvel, Bert L P, Raphael, Martine F, Rijneveld, Anita W, Appel, Inge M, Vlot, Andre J, Versluijs, A Birgitta, van Gelder, Michel, Granzen, Bernd, Janssen, Mirian C H, Rennings, Alexander J M, van de Veerdonk, Frank L, Brons, Paul P T, Bakkeren, Dirk L, Nijziel, Marten R, Vlasveld, L Thom, Swinkels, Dorine W, Donker, Albertine E, Schaap, Charlotte C M, Novotny, Vera M J, Smeets, Roel, Peters, Tessa M A, van den Heuvel, Bert L P, Raphael, Martine F, Rijneveld, Anita W, Appel, Inge M, Vlot, Andre J, Versluijs, A Birgitta, van Gelder, Michel, Granzen, Bernd, Janssen, Mirian C H, Rennings, Alexander J M, van de Veerdonk, Frank L, Brons, Paul P T, Bakkeren, Dirk L, Nijziel, Marten R, Vlasveld, L Thom, and Swinkels, Dorine W

Published
2016

23. Treatment of infantile hemangiomas: therapeutic options in regard to side effects and adverse events - a review of the literature

Author

MS Dermatologie/Allergologie, Cardiologie patientenzorg, Regenerative Medicine and Stem Cells, Apotheek Klinische Farmacie, Zorgeenheid Plastische Chirurgie Medisch, Other research (not in main researchprogram), Raphael, Martine F, Breur, Johannes MPJ, Vlasveld, Florine AE, Elbert, Niels J, Liem, Yves Tb, Kon, Moshe, Breugem, Corstiaan C, Pasmans, Suzanne GMA, MS Dermatologie/Allergologie, Cardiologie patientenzorg, Regenerative Medicine and Stem Cells, Apotheek Klinische Farmacie, Zorgeenheid Plastische Chirurgie Medisch, Other research (not in main researchprogram), Raphael, Martine F, Breur, Johannes MPJ, Vlasveld, Florine AE, Elbert, Niels J, Liem, Yves Tb, Kon, Moshe, Breugem, Corstiaan C, and Pasmans, Suzanne GMA

Published
2016

24. Iron refractory iron deficiency anemia: a heterogeneous disease that is not always iron refractory

Author

MS Dermatologie/Allergologie, Haematologie patientenzorg, Child Health, Donker, Albertine E, Schaap, Charlotte C M, Novotny, Vera M J, Smeets, Roel, Peters, Tessa M A, van den Heuvel, Bert L P, Raphael, Martine F, Rijneveld, Anita W, Appel, Inge M, Vlot, Andre J, Versluijs, A Birgitta, van Gelder, Michel, Granzen, Bernd, Janssen, Mirian C H, Rennings, Alexander J M, van de Veerdonk, Frank L, Brons, Paul P T, Bakkeren, Dirk L, Nijziel, Marten R, Vlasveld, L Thom, Swinkels, Dorine W, MS Dermatologie/Allergologie, Haematologie patientenzorg, Child Health, Donker, Albertine E, Schaap, Charlotte C M, Novotny, Vera M J, Smeets, Roel, Peters, Tessa M A, van den Heuvel, Bert L P, Raphael, Martine F, Rijneveld, Anita W, Appel, Inge M, Vlot, Andre J, Versluijs, A Birgitta, van Gelder, Michel, Granzen, Bernd, Janssen, Mirian C H, Rennings, Alexander J M, van de Veerdonk, Frank L, Brons, Paul P T, Bakkeren, Dirk L, Nijziel, Marten R, Vlasveld, L Thom, and Swinkels, Dorine W

Published
2016

25. Iron refractory iron deficiency anemia: a heterogeneous disease that is not always iron refractory

Author

Donker, Albertine E., primary, Schaap, Charlotte C.M., additional, Novotny, Vera M. J., additional, Smeets, Roel, additional, Peters, Tessa M. A., additional, van den Heuvel, Bert L. P., additional, Raphael, Martine F., additional, Rijneveld, Anita W., additional, Appel, Inge M., additional, Vlot, Andre J., additional, Versluijs, A. Birgitta, additional, van Gelder, Michel, additional, Granzen, Bernd, additional, Janssen, Mirian C.H., additional, Rennings, Alexander J.M., additional, van de Veerdonk, Frank L., additional, Brons, Paul P.T., additional, Bakkeren, Dirk L., additional, Nijziel, Marten R., additional, Vlasveld, L. Thom, additional, and Swinkels, Dorine W., additional

Published
2016
Full Text
View/download PDF

27. Dyskeratosis Congenita: Evaluation of Immune Status and Hematopoietic Stem Cell Transplantation. A Literature and EBMT Data Base Survey of 75 Patients,

Author

Korthof, Elisabeth T, primary, Van der Zalm, Judith, additional, Raphael, Martine F, additional, Bresters, Dorine, additional, Tolar, Jakub, additional, Aljurf, Mahmoud, additional, Veys, Paul, additional, Oneto, Rosi, additional, Bacigalupo, Andrea, additional, Peters, Christina, additional, Gaspar, Bobby, additional, Dufour, Carlo, additional, and Marsh, Judith C. W., additional

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results